Literature DB >> 22122734

Chlamydial infection during trachoma monitoring: are the most difficult-to-reach children more likely to be infected?

Jeremy D Keenan1, J Moncada, T Gebre, B Ayele, M C Chen, S N Yu, P M Emerson, N E Stoller, C E McCulloch, B D Gaynor, J Schachter.   

Abstract

OBJECTIVES: During mass antibiotic distributions for trachoma, certain individuals are difficult to locate and go untreated. These untreated individuals may serve as a source of community reinfection. The importance of this difficult-to-locate, untreated population is unclear. We sought to determine whether individuals who are difficult to locate were more likely to be infected with ocular chlamydia than those who were easier to locate.
METHODS: We monitored 12 Ethiopian communities 1 year after a third annual mass azithromycin treatment for trachoma. Conjunctival swabbing for chlamydial RNA was performed in a random sample of children from each community. If insufficient numbers of children were enrolled on the first monitoring day, we returned on subsequent days.
RESULTS: Of the 12 communities, 10 required more than one monitoring day. On average, 16.1% (95% CI 7.9-30.0) of children were enrolled after the initial day. Evidence of chlamydia was found in 7.1% (95% CI 2.7-17.4) of 0- to 9-year-old children. No ocular swabs collected after the initial day were positive for chlamydial RNA. Children examined after the initial monitoring day were significantly less likely to have ocular chlamydial infection than children seen on the initial day; Mantel-Haenszel common OR = 0 (95% CI 0-0.77).
CONCLUSIONS: In a setting of repeated annual mass azithromycin treatments, after approximately 80% of individuals have been located in a community, extra efforts to find absent individuals may not yield significantly more cases of ocular chlamydia.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22122734      PMCID: PMC3292692          DOI: 10.1111/j.1365-3156.2011.02919.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  18 in total

1.  Comparison of an rRNA-based and DNA-based nucleic acid amplification test for the detection of Chlamydia trachomatis in trachoma.

Authors:  Jon L Yang; Julius Schachter; Jeanne Moncada; Dereje Habte; Mulat Zerihun; Jenafir I House; Zhaoxia Zhou; Kevin C Hong; Kathryn Maxey; Bruce D Gaynor; Thomas M Lietman
Journal:  Br J Ophthalmol       Date:  2006-10-18       Impact factor: 4.638

2.  Magnitude of trachoma and barriers to uptake of lid surgery in a rural community of northern Nigeria.

Authors:  M M Rabiu; A Abiose
Journal:  Ophthalmic Epidemiol       Date:  2001-07       Impact factor: 1.648

3.  A simple system for the assessment of trachoma and its complications.

Authors:  B Thylefors; C R Dawson; B R Jones; S K West; H R Taylor
Journal:  Bull World Health Organ       Date:  1987       Impact factor: 9.408

4.  Comparison of annual versus twice-yearly mass azithromycin treatment for hyperendemic trachoma in Ethiopia: a cluster-randomised trial.

Authors:  Teshome Gebre; Berhan Ayele; Mulat Zerihun; Asrat Genet; Nicole E Stoller; Zhaoxia Zhou; Jenafir I House; Sun N Yu; Kathryn J Ray; Paul M Emerson; Jeremy D Keenan; Travis C Porco; Thomas M Lietman; Bruce D Gaynor
Journal:  Lancet       Date:  2011-12-20       Impact factor: 79.321

5.  Trachoma and ocular Chlamydia trachomatis were not eliminated three years after two rounds of mass treatment in a trachoma hyperendemic village.

Authors:  Sheila K West; Beatriz Munoz; Harran Mkocha; Charlotte Gaydos; Thomas Quinn
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-04       Impact factor: 4.799

Review 6.  Trachoma.

Authors:  Heathcote R Wright; Angus Turner; Hugh R Taylor
Journal:  Lancet       Date:  2008-06-07       Impact factor: 79.321

7.  Feasibility of eliminating ocular Chlamydia trachomatis with repeat mass antibiotic treatments.

Authors:  Muluken Melese; Jaya Devi Chidambaram; Wondu Alemayehu; David Chung Lee; Elizabeth H Yi; Vicky Cevallos; Zhaoxia Zhou; Cathy Donnellan; Michael Saidel; John P Whitcher; Bruce D Gaynor; Thomas M Lietman
Journal:  JAMA       Date:  2004-08-11       Impact factor: 56.272

8.  An epidemiological study of rotavirus diarrhoea in a cohort of Nigerian infants: I. Methodology and experiences in the recruitment and follow-up of patients.

Authors:  C O Oyejide; A H Fagbami
Journal:  Int J Epidemiol       Date:  1988-12       Impact factor: 7.196

9.  A rationale for continuing mass antibiotic distributions for trachoma.

Authors:  Kathryn J Ray; Travis C Porco; Kevin C Hong; David C Lee; Wondu Alemayehu; Muluken Melese; Takele Lakew; Elizabeth Yi; Jenafir House; Jaya D Chidambaram; John P Whitcher; Bruce D Gaynor; Thomas M Lietman
Journal:  BMC Infect Dis       Date:  2007-08-07       Impact factor: 3.090

View more
  7 in total

1.  Diagnostic characteristics of tests for ocular Chlamydia after mass azithromycin distributions.

Authors:  Jeremy D Keenan; Craig W See; Jeanne Moncada; Berhan Ayele; Teshome Gebre; Nicole E Stoller; Charles E McCulloch; Travis C Porco; Bruce D Gaynor; Paul M Emerson; Julius Schachter; Thomas M Lietman
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-01-25       Impact factor: 4.799

Review 2.  Trachoma: an update on prevention, diagnosis, and treatment.

Authors:  Satasuk Joy Bhosai; Robin L Bailey; Bruce D Gaynor; Thomas M Lietman
Journal:  Curr Opin Ophthalmol       Date:  2012-07       Impact factor: 3.761

Review 3.  The Relationship between Active Trachoma and Ocular Chlamydia trachomatis Infection before and after Mass Antibiotic Treatment.

Authors:  Athumani M Ramadhani; Tamsyn Derrick; David Macleod; Martin J Holland; Matthew J Burton
Journal:  PLoS Negl Trop Dis       Date:  2016-10-26

Review 4.  Will the SAFE strategy be sufficient to eliminate trachoma by 2020? Puzzlements and possible solutions.

Authors:  Diane K Lavett; Van C Lansingh; Marissa J Carter; Kristen A Eckert; Juan C Silva
Journal:  ScientificWorldJournal       Date:  2013-05-19

5.  The easiest children to reach are most likely to be infected with ocular Chlamydia trachomatis in trachoma endemic areas of Niger.

Authors:  Abdou Amza; Boubacar Kadri; Baido Nassirou; Sun N Yu; Nicole E Stoller; Satasuk J Bhosai; Zhaoxia Zhou; Charles E McCulloch; Sheila K West; Robin L Bailey; Jeremy D Keenan; Thomas M Lietman; Bruce D Gaynor
Journal:  PLoS Negl Trop Dis       Date:  2013-01-10

6.  The efficacy of oral azithromycin in clearing ocular chlamydia: mathematical modeling from a community-randomized trachoma trial.

Authors:  Fengchen Liu; Travis C Porco; Harran A Mkocha; Beatriz Muñoz; Kathryn J Ray; Robin L Bailey; Thomas M Lietman; Sheila K West
Journal:  Epidemics       Date:  2014-01-08       Impact factor: 4.396

7.  Low Prevalence of Conjunctival Infection with Chlamydia trachomatis in a Treatment-Naïve Trachoma-Endemic Region of the Solomon Islands.

Authors:  Robert M R Butcher; Oliver Sokana; Kelvin Jack; Colin K Macleod; Michael E Marks; Eric Kalae; Leslie Sui; Charles Russell; Helena J Tutill; Rachel J Williams; Judith Breuer; Rebecca Willis; Richard T Le Mesurier; David C W Mabey; Anthony W Solomon; Chrissy H Roberts
Journal:  PLoS Negl Trop Dis       Date:  2016-09-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.